MASI Stock Overview
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide.
Masimo Corporation Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$146.93|
|52 Week High||US$305.21|
|52 Week Low||US$112.07|
|1 Month Change||1.84%|
|3 Month Change||6.91%|
|1 Year Change||-45.34%|
|3 Year Change||2.76%|
|5 Year Change||72.70%|
|Change since IPO||603.01%|
Recent News & Updates
Should You Think About Buying Masimo Corporation (NASDAQ:MASI) Now?
While Masimo Corporation ( NASDAQ:MASI ) might not be the most widely known stock at the moment, it led the NASDAQGS...
|MASI||US Medical Equipment||US Market|
Return vs Industry: MASI underperformed the US Medical Equipment industry which returned -27.3% over the past year.
Return vs Market: MASI underperformed the US Market which returned -20% over the past year.
|MASI Average Weekly Movement||5.9%|
|Medical Equipment Industry Average Movement||8.5%|
|Market Average Movement||6.9%|
|10% most volatile stocks in US Market||15.5%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: MASI is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: MASI's weekly volatility (6%) has been stable over the past year.
About the Company
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index.
Masimo Corporation Fundamentals Summary
|MASI fundamental statistics|
Is MASI overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MASI income statement (TTM)|
|Cost of Revenue||US$623.01m|
Last Reported Earnings
Jul 02, 2022
Next Earnings Date
|Earnings per share (EPS)||3.63|
|Net Profit Margin||12.68%|
How did MASI perform over the long term?See historical performance and comparison